Cargando…

Plasminogen Activator Inhibitor-2 Polymorphism Associates with Recurrent Coronary Event Risk in Patients with High HDL and C-Reactive Protein Levels

The objective of this work was to investigate whether fibrinolysis plays a role in establishing recurrent coronary event risk in a previously identified group of postinfarction patients. This group of patients was defined as having concurrently high levels of high-density lipoprotein cholesterol (HD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corsetti, James P., Salzman, Peter, Ryan, Dan, Moss, Arthur J., Zareba, Wojciech, Sparks, Charles E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706432/ https://www.ncbi.nlm.nih.gov/pubmed/23874812 http://dx.doi.org/10.1371/journal.pone.0068920

Ejemplares similares

Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling
por: Corsetti, James P., et al.
Publicado: (2016)

The common apolipoprotein A-1 polymorphism −75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction
por: Block, Robert, et al.
Publicado: (2009)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events
por: Szepietowska, Barbara, et al.
Publicado: (2016)

Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk
por: Corsetti, James P., et al.
Publicado: (2019)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Association of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent pregnancy loss in Iranian women
por: Shakarami, Fatemeh, et al.
Publicado: (2015)

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower
por: Dayco, John, et al.
Publicado: (2022)

t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension
por: Katta, Sujana, et al.
Publicado: (2008)

Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor‐1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
por: Corban, Michel T., et al.
Publicado: (2018)

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
por: Al-Hamodi, Zaid, et al.
Publicado: (2012)

Tissue plasminogen activator and plasminogen activator inhibitor type 1 gene polymorphism in patients with gastric ulcer complicated with bleeding.
por: Kim, Hong-Soo, et al.
Publicado: (2003)

Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation
por: Le, Nhat-Tu, et al.
Publicado: (2012)

Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss
por: Li, Xuejiao, et al.
Publicado: (2015)

The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population
por: Park, Han Sung, et al.
Publicado: (2020)

Spasmogenic Effects of the Proteasome Inhibitor Carfilzomib on Coronary Resistance, Vascular Tone and Reactivity
por: Chen-Scarabelli, Carol, et al.
Publicado: (2017)

Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events
por: Magnoni, Marco, et al.
Publicado: (2022)

Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
por: Song, Ci, et al.
Publicado: (2017)

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects
por: Kahri, Juhani, et al.
Publicado: (2006)

ABO gene polymorphisms are associated with acute coronary syndrome and with plasma concentration of HDL-cholesterol and triglycerides
por: Vargas-Alarcón, Gilberto, et al.
Publicado: (2023)

Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
por: Lee, Wen-Chin, et al.
Publicado: (2021)

Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: Hancock-Cerutti, William, et al.
Publicado: (2021)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Sex-dependent relationship of C-reactive protein levels with HDL-cholesterol and HDL-phospholipid concentrations in children
por: Vales-Villamarín, Claudia, et al.
Publicado: (2022)

Delayed recurrence of acute subdural hematoma in a patient with plasminogen activator inhibitor mutation
por: Aljuboori, Zaid, et al.
Publicado: (2020)

Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease
por: Zhang, Ai Yuan, et al.
Publicado: (2010)

Lack of association between Ser(413)/Cys polymorphism of plasminogen activator inhibitor type 2 (PAI-2) and premature coronary atherosclerotic disease
por: Saffari, Babak, et al.
Publicado: (2012)

Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
por: Song, J., et al.
Publicado: (2000)

WRN polymorphisms affect expression levels of plasminogen activator inhibitor type 1 in cultured fibroblasts
por: Castro, Elena, et al.
Publicado: (2008)

Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
por: Jimenez, J, et al.
Publicado: (2007)

Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis
por: Li, Yan-yan
Publicado: (2012)

Association of the T+294C polymorphism in PPAR δ with low HDL cholesterol and coronary heart disease risk in women
por: Aberle, Jens, et al.
Publicado: (2006)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients with Coronary Artery Disease
por: Forood, Afsaneh, et al.
Publicado: (2014)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes
por: Costacou, Tina, et al.
Publicado: (2023)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7h3m9qnpmc7lr097cd1b69vhvi